Synthetic opioids

FILE - In this Oct. 14, 2010 file photo, musician Prince holds a news conference at The Apollo Theater announcing his "Welcome 2 America" tour in New York. The ongoing controversy over the money left behind by Prince when he died without a will is heating up again after Internal Revenue Service calculations showed that executors of the rock star's estate undervalued it by 50%, or about $80 million. (AP Photo/Peter Kramer, File)

FILE - In this April 26, 2018, file photo, a man lies on the sidewalk beside a recyclable trash bin in San Francisco. A record 621 people died of drug overdoses in San Francisco so far this year, a staggering number that far outpaces the 173 deaths from COVID-19 the city has seen thus far. The crisis fueled by the powerful painkiller fentanyl could have been far worse if it wasn't for the nearly 3,000 times Narcan was used from January to the beginning of November to save someone from the brink of death, the San Francisco Chronicle reported Saturday, Dec. 19, 2020. (AP Photo/Ben Margot, File)

In this image from House Television, David Sackler, a member of the family that owns Purdue Pharma testifies via video to a House Oversight Committee hearing Thursday, Dec. 17, 2020. Members of the family that owns OxyContin maker Purdue Pharma have acknowledged the drug had a role in the opioid crisis but have stopped short of apologizing or admitting wrongdoing. (House Television via AP)

FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. A bipartisan congressional investigation released Wednesday, Dec. 16, 2020, found that key players in the nation’s opioid industry have spent $65 million since 1997 funding nonprofits that advocate treating pain with medications, a strategy intended to boost the sale of prescription painkillers. (AP Photo/Toby Talbot, File)

FILE - This Oct. 21, 2020 file photo shows Purdue Pharma headquarters in Stamford, Conn. Two members of the Sackler family have agreed to make a rare public appearance to take questions from a congressional committee that is investigating the role of the company they own, Purdue Pharma, in fueling the nation's opioid epidemic. The agreement to appear Thursday, Dec. 17 headed off the possibility of the U.S. House Oversight Committee issuing subpoenas. (AP Photo/Mark Lennihan, File)

FILE - In this Aug. 3, 2020 file photo, Oklahoma Attorney General Mike Hunter speaks during a news conference in Oklahoma City. Oklahoma has asked the state Supreme Court to order Johnson & Johnson to pay more than $9.3 billion to cover the anticipated cost of combating the state's opioid crisis. Attorney General Mike Hunter made the request Monday, Dec. 7, 2020. (AP Photo/Sue Ogrocki File)

FILE - In this Aug. 15, 2019 file photo, marijuana grows at an indoor cannabis farm in Gardena, Calif. On Monday, Nov. 23, 2020, cannabis stocks are flying high this month after voters in four states passed measures clearing the way for sales of marijuana to adults. That alone is projected to boost the market for legal cannabis sales in the U.S. by 20%. (AP Photo/Richard Vogel, File)

FILE - In this Tuesday, May 8, 2007, file photo, a Purdue Pharma logo is affixed to part of a Purdue building in Stamford, Conn. Proposed settlements between the federal government and OxyContin maker Purdue Pharma and its owners cleared a major legal hurdle Tuesday, Nov. 17, 2020, when a bankruptcy judge said they could move ahead. (AP Photo/Douglas Healey, File)

FILE - This June 26, 2020 file photo from video provided by the Yes on Measure 110 Campaign shows volunteers delivering boxes containing signed petitions in favor of the measure to the Oregon Secretary of State's office in Salem. The measure said the U.S., possession of small amounts of heroin, cocaine, LSD and other hard drugs would be decriminalized in Oregon. Election returns show the measure passed on Election Day, Tuesday, Nov. 3. (Yes on Measure 110 Campaign via AP, File)